RVVTFRevive TherapeuticsRVVTF info
$0.01info3.33%24h
Global rank5912
Market cap$2.10M
Change 7d3.33%
YTD Performance-65.56%
SP500 benchmarkUnderperform
P/E-0.31
P/S0
Revenue$0
Earnings$0
Dividend yield-

Revive Therapeutics (RVVTF) Stock Overview

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is based in Toronto, Canada.

RVVTF Stock Information

Symbol
RVVTF
Address
The Canadian Venture BuildingToronto, ON M5C 1P1Canada
Founded
-
Trading hours
-
Website
https://revivethera.com
Country
🇨🇦 Canada
Phone Number
888-901-0036

Revive Therapeutics (RVVTF) Price Chart

-
Value:-

Revive Therapeutics Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.0062000002
N/A
Market Cap
$2.10M
N/A
Shares Outstanding
339.37M
6.13%
Employees
0
N/A
Shareholder Equity
10.65M
-15.47%
Valuation
2023
Change
P/E Ratio
-0.31
N/A
P/B Ratio
0.20
N/A
Earnings
2023
Change
EPS
-0.02
N/A
Earnings Yield
-3.23
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org